URACHAL ABSCESS

This adverse event was reported 4 times

These drugs are most commonly taken by patients reporting URACHAL ABSCESS:

# Drug Count
0 ALPRAZOLAM 1
1 AMOXAPINE 1
2 DICLOFENAC SODIUM 1
3 INFLIXIMAB 1
4 METHYLPREDNISOLONE 1
5 MIRTAZAPINE 1
6 SUCRALFATE 1
7 SUCRALFATE ORAL 1
8 SUCRALFATE ORAL SUSPENSION 1
9 TACROLIMUS 1
See all common drugs associated with URACHAL ABSCESS

URACHAL ABSCESS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AMOXAPINE 1 0.0021
1 SUCRALFATE 1 0.0000
2 MIRTAZAPINE 1 0.0000
3 TACROLIMUS OINTMENT 0.1% 1 0.0000
4 TACROLIMUS EXTENDED-RELEASE CAPSULES 1 0.0000
5 METHYLPREDNISOLONE 1 0.0000
6 DICLOFENAC SODIUM 1 0.0000
7 TACROLIMUS 1 0.0000
8 ALPRAZOLAM 1 0.0000
9 INFLIXIMAB 1 0.0000
See all drugs enriched for association with URACHAL ABSCESS

These drug classes are most commonly taken by patients reporting URACHAL ABSCESS:

# Drug class Count
0 Aluminum Complex [EPC] 1
1 Benzodiazepine [EPC] 1
2 Corticosteroid [EPC] 1
3 Tricyclic Antidepressant [EPC] 1
4 Tumor Necrosis Factor Blocker [EPC] 1
See all common drug classes associated with URACHAL ABSCESS

URACHAL ABSCESS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Tricyclic Antidepressant [EPC] 1 0.0021
1 Aluminum Complex [EPC] 1 0.0000
2 Benzodiazepine [EPC] 1 0.0000
3 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
4 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with URACHAL ABSCESS